What is the Purpose of this Study?
We are doing this study to learn what effects, good or bad, atezolizumab has on you and your cancer when combined with bevacizumab and to make sure it is safe.
What is the Condition Being Studied?
Who Can Participate in this Study?
- Have advanced or metastatic and/or unresectable hepatocellular carcinoma
What is Involved?
If you choose to join this study, you will:
- Receive either atezolizumab or atezolizumab and bevacizumab every 3 weeks through a vein in your arm
-- Continue to receive the study drug as long as your doctor thinks it is safe
An Open-Label, Multicenter Phase Ib Study of the Safety and Efficacy of Atezolizumab (Anti-PD-L1 Antibody) Administered in Combination With Bevacizumab and/or Other Treatments in Patients With Solid Tumors
View on ClinicalTrials.gov